Overview

Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections

Status:
Recruiting

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

This clinical study evaluates the efficacy of the autologous blood-derived product called platelet- and extracellular vesicle-rich plasma as a supplement to the surgical treatment of chronic tympanic membrane perforations. Half of the participants will be treated with standard surgical procedure called tympanoplasty and addition of platelet- and extracellular vesicle-rich plasma. Another half will be treated with only the standard tympanoplasty.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University Medical Centre Ljubljana

Collaborator:

University of Ljubljana